Abstract: The present disclosure relates to cisplatin nanoparticle compositions and a method for the preparation thereof. A phospholipid complex of cisplatin is prepared for increased absorption, followed by the phospholipid complex is converted into lipid nanoparticles by choosing appropriate solvents, incorporation of lipids, stabilizers under optimum conditions of agitation, temperature and solvent evaporated under reduced pressure. The incorporation of lipids and stabilizers for the formulation of nanoparticles based cisplatin leads to the formation of micelles and mixed micelles that enhance the cisplatin absorption into systemic circulation because of the nano size and by lymphatic transport. The nanoparticle based composition of cisplatin that is administered orally. It is safe, effective, convenient and affordable to the patient.

Abstract: A lubricant formulation of carbamoylethyl katira and a microwave assisted process for the preparation of the lubricant formulation of carbamoylethyl katira. The lubricant formulation of carbamoylethyl katira having antibacterial activity useful for eye lubricant based formulations, treatment of dry eye disease syndrome, etc.

Abstract: A lubricant formulation of carbamoylethyl katira and a microwave assisted process for the preparation of the lubricant formulation of carbamoylethyl katira. The lubricant formulation of carbamoylethyl katira having antibacterial activity useful for eye lubricant based formulations, treatment of dry eye disease syndrome, etc.